Previous 10 | Next 10 |
Elite Pharmaceuticals, Inc. (ELTP) Q4 2021 Earnings Conference Call June 15, 2021, 11:30 AM ET Company Participants Nasrat Hakim - Chairman and CEO Marc Bregman - Chief Financial Officer Conference Call Participants Presentation Operator Good morning, ladies and gentlemen. And welcome to the ...
Conference Call Scheduled for Tuesday, June 15 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 14, 2021 / Elite Pharmaceuticals, Inc. ('Elite' or the "Company')(OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the fiscal year end...
Financials for Fiscal Year Ended March 31, 2021 will be released June 14, 2021 NORTHVALE, NJ / ACCESSWIRE / June 8, 2021 / Elite Pharmaceuticals, Inc. ('Elite' or the "Company') (OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, announced today that it w...
Elite Pharmaceuticals ([[ELTP]] -3.5%) enters a license, supply, and distribution agreement with Prasco for Elite's Abbreviated New Drug Application for Loxapine Succinate capsules.Prasco will be the exclusive U.S. distributor for Loxapine capsules, which will be marketed ...
NORTHVALE, NJ / ACCESSWIRE / May 4, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that its distribution and marketing partner Prasco, LLC ("Prasco"), has launched Elite's generic Loxapine capsules. Elite entered a license, supply, and distributio...
Elite Pharmaceuticals (ELTP) announces that Marc Bregman has been appointed as Chief Financial Officer, effective May 17, 2021.Bregman has more than 27 years of financial and operational experience, including positions as Controller at Langan Engineering & Environmental Ser...
NORTHVALE, NJ / ACCESSWIRE / April 29, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, announced today that Marc Bregman, CPA, has been appointed as Chief Financial Officer (CF...
Elite Pharmaceuticals, Inc. (ELTP) Q3 2021 Earnings Conference Call February 17, 2021 11:30 AM ET Company Participants Nasrat Hakim - President & Chief Executive Officer Carter Ward - Chief Financial Officer Conference Call Participants Presentation Operator Good morning, ladies and gentl...
Elite Pharmaceuticals (ELTP): FQ3 GAAP EPS of $0.00.Revenue of $6.05M (+19.6% Y/Y)10QPress Release For further details see: Elite Pharmaceuticals reports FQ3 results
Conference Call Scheduled for Wednesday, February 17 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 16, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, announced re...
News, Short Squeeze, Breakout and More Instantly...
Elite Pharmaceuticals Inc. Company Name:
ELTP Stock Symbol:
OTCMKTS Market:
Elite Pharmaceuticals Inc. Website:
Financials for Fiscal Year 2024 Ended March 31, 2024 will be released on July 1, 2024 Northvale, New Jersey--(Newsfile Corp. - June 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced to...